171 related articles for article (PubMed ID: 26035340)
21. Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases.
Rezzola S; Paganini G; Semeraro F; Presta M; Tobia C
Biochim Biophys Acta; 2016 Jul; 1862(7):1291-6. PubMed ID: 27085972
[TBL] [Abstract][Full Text] [Related]
22. FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice.
Fu Z; Gong Y; Liegl R; Wang Z; Liu CH; Meng SS; Burnim SB; Saba NJ; Fredrick TW; Morss PC; Hellstrom A; Talukdar S; Smith LE
Cell Rep; 2017 Feb; 18(7):1606-1613. PubMed ID: 28199833
[TBL] [Abstract][Full Text] [Related]
23. Antiangiogenesis effects of endostatin in retinal neovascularization.
Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
[TBL] [Abstract][Full Text] [Related]
24. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
25. Homoisoflavanone inhibits retinal neovascularization through cell cycle arrest with decrease of cdc2 expression.
Kim JH; Kim KH; Kim JH; Yu YS; Kim YM; Kim KW; Kwon HJ
Biochem Biophys Res Commun; 2007 Nov; 362(4):848-52. PubMed ID: 17803958
[TBL] [Abstract][Full Text] [Related]
26. In vitro and ex vivo retina angiogenesis assays.
Rezzola S; Belleri M; Gariano G; Ribatti D; Costagliola C; Semeraro F; Presta M
Angiogenesis; 2014 Jul; 17(3):429-42. PubMed ID: 24121991
[TBL] [Abstract][Full Text] [Related]
27. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H
N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858
[TBL] [Abstract][Full Text] [Related]
28. Anti-angiogenic effect of caffeic acid on retinal neovascularization.
Kim JH; Lee BJ; Kim JH; Yu YS; Kim KW
Vascul Pharmacol; 2009 Oct; 51(4):262-7. PubMed ID: 19589397
[TBL] [Abstract][Full Text] [Related]
29. The tumour neovasculature-homing dimeric peptide GX1 demonstrates antiangiogenic activity in the retinal neovasculature.
Luo Y; Yin J; Fang R; Liu J; Wang L; Zhang H; Zhang M; Lei Z; Liang S; Cui W; Zhang Z; Wu K; Hui X
Eur J Pharmacol; 2021 Dec; 912():174574. PubMed ID: 34662566
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and mechanistic studies of a novel homoisoflavanone inhibitor of endothelial cell growth.
Basavarajappa HD; Lee B; Fei X; Lim D; Callaghan B; Mund JA; Case J; Rajashekhar G; Seo SY; Corson TW
PLoS One; 2014; 9(4):e95694. PubMed ID: 24752613
[TBL] [Abstract][Full Text] [Related]
31. β-LGND2, an ERβ selective agonist, inhibits pathologic retinal neovascularization.
Giddabasappa A; Eswaraka JR; Barrett CM; Bauler MN; Wu Z; Yepuru M; Miller DD; Dalton JT
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):5066-75. PubMed ID: 22714897
[TBL] [Abstract][Full Text] [Related]
32. Bufadienolides and anti-angiogenic homoisoflavonoids from Rhodocodon cryptopodus, Rhodocodon rotundus and Rhodocodon cyathiformis.
Whitmore H; Sishtla K; Knirsch W; Andriantiana JL; Schwikkard S; Mas-Claret E; Nassief SM; Isyaka SM; Corson TW; Mulholland DA
Fitoterapia; 2020 Mar; 141():104479. PubMed ID: 31927011
[TBL] [Abstract][Full Text] [Related]
33. A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy.
Sulaiman RS; Merrigan S; Quigley J; Qi X; Lee B; Boulton ME; Kennedy B; Seo SY; Corson TW
Sci Rep; 2016 May; 6():25509. PubMed ID: 27148944
[TBL] [Abstract][Full Text] [Related]
34. Studies with an orally bioavailable alpha V integrin antagonist in animal models of ocular vasculopathy: retinal neovascularization in mice and retinal vascular permeability in diabetic rats.
Santulli RJ; Kinney WA; Ghosh S; Decorte BL; Liu L; Tuman RW; Zhou Z; Huebert N; Bursell SE; Clermont AC; Grant MB; Shaw LC; Mousa SA; Galemmo RA; Johnson DL; Maryanoff BE; Damiano BP
J Pharmacol Exp Ther; 2008 Mar; 324(3):894-901. PubMed ID: 18083913
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic efficacy of a novel non-peptide αvβ3 integrin antagonist for pathological retinal angiogenesis in mice.
Li YJ; Li XH; Wang LF; Kuang X; Hang ZX; Deng Y; Du JR
Exp Eye Res; 2014 Dec; 129():119-26. PubMed ID: 25446322
[TBL] [Abstract][Full Text] [Related]
36. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
[TBL] [Abstract][Full Text] [Related]
37. The HIF-1 antagonist acriflavine: visualization in retina and suppression of ocular neovascularization.
Zeng M; Shen J; Liu Y; Lu LY; Ding K; Fortmann SD; Khan M; Wang J; Hackett SF; Semenza GL; Campochiaro PA
J Mol Med (Berl); 2017 Apr; 95(4):417-429. PubMed ID: 28004126
[TBL] [Abstract][Full Text] [Related]
38. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
[TBL] [Abstract][Full Text] [Related]
39. Honokiol inhibits pathological retinal neovascularization in oxygen-induced retinopathy mouse model.
Vavilala DT; O'Bryhim BE; Ponnaluri VK; White RS; Radel J; Symons RC; Mukherji M
Biochem Biophys Res Commun; 2013 Sep; 438(4):697-702. PubMed ID: 23921228
[TBL] [Abstract][Full Text] [Related]
40. Mammalian Target of Rapamycin (mTOR) as a Potential Therapeutic Target in Pathological Ocular Angiogenesis.
Nakahara T; Morita A; Yagasaki R; Mori A; Sakamoto K
Biol Pharm Bull; 2017; 40(12):2045-2049. PubMed ID: 29199229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
